Michael S Grabinski, MD, MPH | |
904 7th Ave, 8th Floor, Seattle, WA 98104-1132 | |
(206) 860-4424 | |
(206) 720-7424 |
Full Name | Michael S Grabinski |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 16 Years |
Location | 904 7th Ave, Seattle, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003066366 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 4301093158 (Michigan) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Skokomish Tribal Council | 7719060375 | 4 |
News Archive
Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company's fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher's U.S. marketing and distribution partner, which will be reflected in Cipher's revenue for the second quarter of fiscal 2010.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
New research on two promising gene therapies suggests that combining them into one treatment not only repairs muscle damage caused by Duchenne muscular dystrophy, but also prevents future injury from the muscle-wasting disease.
Today's health policy news includes reports foreshadowing possible Senate action on repealing the health overhaul.
› Verified 1 days ago
Entity Name | Skokomish Tribal Council |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316056096 PECOS PAC ID: 7719060375 Enrollment ID: O20080206000263 |
News Archive
Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company's fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher's U.S. marketing and distribution partner, which will be reflected in Cipher's revenue for the second quarter of fiscal 2010.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
New research on two promising gene therapies suggests that combining them into one treatment not only repairs muscle damage caused by Duchenne muscular dystrophy, but also prevents future injury from the muscle-wasting disease.
Today's health policy news includes reports foreshadowing possible Senate action on repealing the health overhaul.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Michael S Grabinski, MD, MPH 904 7th Ave, 8th Floor, Seattle, WA 98104-1132 Ph: (206) 860-4424 | Michael S Grabinski, MD, MPH 904 7th Ave, 8th Floor, Seattle, WA 98104-1132 Ph: (206) 860-4424 |
News Archive
Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company's fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher's U.S. marketing and distribution partner, which will be reflected in Cipher's revenue for the second quarter of fiscal 2010.
Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
New research on two promising gene therapies suggests that combining them into one treatment not only repairs muscle damage caused by Duchenne muscular dystrophy, but also prevents future injury from the muscle-wasting disease.
Today's health policy news includes reports foreshadowing possible Senate action on repealing the health overhaul.
› Verified 1 days ago
Claire M Barnett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 E Madison St, Seattle, WA 98122 Phone: 206-328-7722 Fax: 206-720-4657 | |
Dr. Gregory Parada, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8720 14th Ave S, Seattle, WA 98108 Phone: 206-762-3730 Fax: 206-764-5494 | |
Xin Jie Luo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Fauntleroy Way Sw, Seattle, WA 98116 Phone: 206-201-0551 Fax: 206-201-0552 | |
Brooke Elizabeth Parker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11011 Meridian Ave N Ste 201, Seattle, WA 98133 Phone: 206-520-5000 | |
Eunice Mbela Nachinga, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 125 16th Ave E # Csb545, Seattle, WA 98112 Phone: 206-326-3769 | |
Michelle K Xu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 Madison St Ste 100, Seattle, WA 98104 Phone: 206-386-6111 Fax: 206-386-6113 |